Form 4: Encompass Health EVP Douglas Coltharp Executes Stock Option and Sells Shares
SEC Form 4 Filing
Encompass Health's EVP & CFO, Douglas Coltharp, exercised stock options and sold shares on August 13, 2024, according to a Form 4 filing with the SEC.
Summary
- On August 13, 2024, Douglas E. Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, exercised non-qualified stock options to acquire 12,260 shares of Encompass Health common stock at a price of $35.83 per share.
- Simultaneously, Coltharp sold 12,162 shares at a weighted average price of $86.33, with prices ranging from $85.93 to $86.73.
- He also sold 98 shares at a weighted average price of $87.03, with prices ranging from $87.03 to $87.04.
- Following these transactions, Coltharp directly owns 136,227 shares and indirectly owns 125,631 shares through an irrevocable trust for the benefit of his children.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which is neutral in sentiment. It reflects routine financial activity.
Industry Context
This filing reflects routine insider transactions and provides insight into executive compensation and stock ownership at Encompass Health. It's common for executives to exercise stock options and sell a portion of the acquired shares for personal financial management.
Comparison to Industry Standards
- Executive compensation practices, including stock options, are common across publicly traded healthcare companies.
- Comparing Coltharp's stock option grants and exercises to those of CFOs at comparable companies like Select Medical (SEM) or Addus HomeCare (ADUS) would provide a benchmark.
- Analyzing the vesting schedules and exercise prices relative to market prices can indicate the attractiveness of the compensation package.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
- The filing provides transparency to stakeholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/03/2016 | Date of non-qualified stock option grant. |
| 03/03/2025 | Expiration date of non-qualified stock options. |
| 08/13/2024 | Date of transaction: exercise of stock options and sale of shares. |
| 08/14/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.